SecBot SecBot
DEFA14A ·Filed Apr 21, 2026

TRVI

Trevi Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001193125-26-166693
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine annual meeting with no immediate financial impact. Monitor for any changes in governance or compensation policies.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$14.80
T+0 close · Apr 21, 2026 · via day close
Latest settled
+28.85%
T+60 · $19.07
Vs SPY
+24.07%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 22 $14.80entry
  2. T+1 · 7mo ago −4.12%α −3.73% · $14.19
  3. T+5 · 7mo ago −7.97%α −8.03% · $13.62
  4. T+20 · 6mo ago −10.54%α −13.71% · $13.24
  5. T+60 · 4mo ago +28.85%α +24.07% · $19.07
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Trevi Therapeutics is holding its 2026 annual meeting where shareholders will vote on several proposals including electing a director, ratifying auditors, approving executive compensation, amending the stock incentive plan, and increasing authorized shares. This is a routine annual shareholder meeting.

Key Financial Metrics

Vote
director election
Meeting
2026-06-03

Key Facts

  • Annual meeting to vote on director election, auditor ratification, executive compensation, stock incentive plan amendment, and share authorization
  • Board recommends voting for all proposals
  • Meeting date: June 3, 2026

Financial Impact

No immediate financial impact

sharescompensationgovernance

Risk Factors

  • Potential shareholder dissent on executive compensation
  • Possible opposition to share increase

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-166693
Document: 0001193125-26-166693-index-headers.html0001193125-26-166693
Document: 0001193125-26-166693-index.html0001193125-26-166693
Document: 0001193125-26-166693.txt0001193125-26-166693

Track record

12 reports on TRVI

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +15.38% at T+60 after the Mar 9, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 9, 20267d ago 8-K Neutral 4/10 Entry $14.91 Now $13.29 −10.87% settles Dec 9
  2. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $13.52 Now $13.29 −1.70% settles Nov 25
  3. Jun 11, 202622w ago Institutional Cluster Mixed 5/10 Entry $13.46 to $18.40 Now $13.29 −1.26% ▲ +36.70% +34.81% vs SPY
  4. Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $13.46 to $18.40 Now $13.29 −1.26% ▲ +36.70% +34.81% vs SPY
  5. Apr 21, 202629w ago DEFA14A Neutral 3/10 Viewing Entry $14.80 to $13.24 Now $13.29 −10.20% ▼ −10.54% −13.71% vs SPY
  6. Apr 20, 202630w ago Press Release Neutral 5/10 Entry $14.62 to $13.43 Now $13.29 −9.10% ▼ −8.14% −13.05% vs SPY
  7. Apr 17, 202630w ago 424B5 Bearish 7/10 Entry $15.40 to $13.43 Now $13.29 +13.70% ▲ +12.79% +16.99% vs SPY
  8. Apr 17, 202630w ago 8-K Bearish 7/10 Entry $15.23 to $15.08 Now $13.29 +12.74% ▲ +0.98% +6.36% vs SPY
  9. Apr 16, 202630w ago Press Release Neutral 6/10 Entry $15.23 to $15.08 Now $13.29 −12.74% ▼ −0.98% −6.36% vs SPY
  10. Mar 17, 202634w ago Press Release Mixed 6/10 Entry $10.69 to $14.54 Now $13.29 +24.32% ▲ +36.02% +29.97% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 6h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026